Correlation Between Catalyst Biosciences and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Catalyst Biosciences and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Biosciences and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Biosciences and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Catalyst Biosciences and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Biosciences with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Biosciences and Crinetics Pharmaceuticals.
Diversification Opportunities for Catalyst Biosciences and Crinetics Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Catalyst and Crinetics is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Biosciences and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Catalyst Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Biosciences are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Catalyst Biosciences i.e., Catalyst Biosciences and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Catalyst Biosciences and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Catalyst Biosciences is expected to generate 1.5 times more return on investment than Crinetics Pharmaceuticals. However, Catalyst Biosciences is 1.5 times more volatile than Crinetics Pharmaceuticals. It trades about 0.32 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.08 per unit of risk. If you would invest 22.00 in Catalyst Biosciences on August 31, 2024 and sell it today you would earn a total of 19.00 from holding Catalyst Biosciences or generate 86.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 8.56% |
| Values | Daily Returns |
Catalyst Biosciences vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Catalyst Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Crinetics Pharmaceuticals |
Catalyst Biosciences and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Biosciences and Crinetics Pharmaceuticals
The main advantage of trading using opposite Catalyst Biosciences and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Biosciences position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Catalyst Biosciences vs. Akari Therapeutics PLC | Catalyst Biosciences vs. Benitec Biopharma Ltd | Catalyst Biosciences vs. Pulmatrix |
| Crinetics Pharmaceuticals vs. Cue Biopharma | Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. Inhibrx | Crinetics Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |